Sign In
Buy CLOV
$3.65
-0.0800 (-2.14%)
At Close: Jun 03, 2026
WILMINGTON, Del., July 31, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover Health”), a physician enablement company bringing access to great healthcare to everyon
Counterpart Health Appoints Vicky Bruner as Vice President of Operations to Support Expansion and Customer Execution
04:30pm, Tuesday, 29'th Jul 2025
WILMINGTON, Del., July 29, 2025 (GLOBE NEWSWIRE) -- Counterpart Health, Inc. (“Counterpart”), a wholly owned subsidiary of Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover
OSCR vs. CLOV: Which Stock Is A Better Buy Now?
06:08am, Monday, 28'th Jul 2025
In this piece, we'll check in on two mid-cap health insurance plays that are leveraging their tech-savvy and digital strengths to grab a bigger slice of the health insurance industry.
TotalEnergies - Angola: Start-up of BEGONIA and CLOV Phase 3 Offshore Projects
09:42am, Wednesday, 23'rd Jul 2025
PARIS--(BUSINESS WIRE)--TotalEnergies (Paris:TTE) (LSE:TTE) (NYSE:TTE) announces the start of production from the BEGONIA and CLOV Phase 3 offshore projects, leveraging ullage in the PAZFLOR and CLOV
Clover Health to Participate in Upcoming Canaccord Genuity 45th Annual Growth Conference
04:05pm, Monday, 21'st Jul 2025
WILMINGTON, Del., July 21, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that its Chief Financial O
Clover Health Appoints Joseph Oldakowski as Vice President of Finance and Controller
08:30am, Thursday, 17'th Jul 2025
WILMINGTON, Del., July 17, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover Health”), a physician enablement company bringing access to great healthcare to everyon
Clover Health Launches New Jersey Community Pharmacy Program in Partnership with IPC's iCare+ Network
08:30am, Wednesday, 09'th Jul 2025
WILMINGTON, Del., July 09, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover Health”), a leading Medicare Advantage company committed to affordable, high-quality ca
Clover Health to Report Second Quarter 2025 Financial Results on August 5, 2025
08:30am, Tuesday, 08'th Jul 2025
WILMINGTON, Del., July 08, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that it will release its f
Clover Health Set to Join Russell 3000® Index
08:30am, Monday, 30'th Jun 2025
WILMINGTON, Del., June 30, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover Health”), announced that it is set to join the broad-market Russell 3000® Index, effec
All You Need to Know About Clover Health Investments (CLOV) Rating Upgrade to Strong Buy
01:05pm, Monday, 12'th May 2025
Clover Health Investments (CLOV) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Clover Health: Stars Are Aligning For GAAP Profitability In FY 2026
08:00am, Sunday, 11'th May 2025
Clover reported impressive Q1 earnings with robust topline growth and improving profitability metrics thanks to a 30% YoY increase in its member base. Clover could see $95 million in additional revenu
CLOV Stock Rises as Q1 Earnings Beat Estimates, Revenues Up Y/Y
01:30pm, Wednesday, 07'th May 2025
Clover Health's first-quarter 2025 results continue to benefit from the strength of its strong member retention. A decline in operating loss bodes well.
Clover Health Investments, Corp. (CLOV) Q1 2025 Earnings Call Transcript
08:34pm, Tuesday, 06'th May 2025
Clover Health Investments, Corp. (NASDAQ:CLOV ) Q1 2025 Earnings Conference Call May 6, 2025 5:00 PM ET Company Participants Ryan Schmidt - Investor Relations Andrew Toy - Chief Executive Officer Pete
Clover Health Investments, Corp. (CLOV) Surpasses Q1 Earnings Estimates
07:00pm, Tuesday, 06'th May 2025
Clover Health Investments, Corp. (CLOV) came out with quarterly earnings of $0.05 per share, beating the Zacks Consensus Estimate of a loss of $0.07 per share. This compares to loss of $0.05 per share
Clover Health Reports First Quarter 2025 Results and Improves Full Year 2025 Guidance
04:05pm, Tuesday, 06'th May 2025
First quarter 2025 Medicare Advantage membership of 103,418, up 30% year-over-year First quarter 2025 Total revenues of $462 million, up 33% year-over-year Medicare Advantage medical costs are in line
